$2.7B raised across 7 disclosed IPO deals.
Last updated · Jun 25, 2026, 4:04 AM UTC · RSS
| Date | Company | Amount | Round | Sector | Country | Lead investors |
|---|---|---|---|---|---|---|
| Jun 18, 26 | Turtlemint Fintech Solutions Ltd Turtlemint Fintech Solutions Ltd operates a technology-led insurance distribution platform that connects customers, insurers, and digital partners. The company has facilitated the distribution of millions of insurance policies and has a significant network of digital partners, including Point of Sales Persons. This funding round will support its growth as it prepares for an IPO. | $47.8M | IPO | Fintech | India | ICICI Prudential Equity & Debt Fund, Mirae Asset Multicap Fund, Mirae Asset Aggressive Hybrid Fund+5 |
| Jun 18, 26 | Kardigan Kardigan is a cardiovascular drug startup focused on developing innovative treatments for heart conditions. The company has raised significant funding through both private venture capital and an initial public offering, highlighting its rapid growth and the increasing interest in biotech investments. Its lead drug, danicamtiv, is in late-stage testing for dilated cardiomyopathy, a condition currently lacking approved treatments. | $400.0M | IPO | Health | United States | — |
| Jun 15, 26 | Razorpay Razorpay is a comprehensive payments and financial services platform that caters primarily to small businesses and startups. Founded in 2014, it has established a significant presence in the fintech sector, serving over 80 lakh businesses. The company is currently seeking to raise between $600 million and $700 million through a confidential IPO, targeting a valuation of $5 billion to $6 billion. | $600.0M | IPO | Fintech | India | Tiger Global, Y Combinator, Lightspeed |
| Jun 10, 26 | Parabilis Medicines Parabilis Medicines is a biotechnology startup focused on developing therapies for 'undruggable' targets, particularly in cancer treatment. The company has raised significant funding to advance its innovative peptide drugs, known as 'Helicons', which aim to target difficult-to-reach cancer-driving proteins. Their most advanced candidate, zolucatetide, is set to enter Phase 3 trials for desmoid tumors in 2027. | $670.0M | IPO | Health | United States | Regeneron Pharmaceuticals |
| Jun 07, 26 | Sunshine Silver Mining Sunshine Silver Mining is focused on the exploration and development of silver mining projects. The company aims to capitalize on the growing demand for silver in various industries, including electronics and renewable energy. This IPO marks a significant milestone for the company as it raises substantial capital to further its operations. | $270.0M | IPO | Other | United States | — |
| Jun 04, 26 | Kuku Technologies Kuku Technologies is a digital entertainment startup that operates a portfolio of apps including Kuku TV, Kuku FM, and Guru. The company focuses on microdramas and audio storytelling, aiming to cater to the growing demand for engaging content in India. | $360.0M | IPO | ConsumerTech | India | — |
| Jun 04, 26 | Kuku Kuku is planning to file for an IPO to raise up to $360 million. The company is valued at $1.8 billion, indicating significant investor interest and market confidence. | $360.0M | IPO | — | — | — |
Filtered to your country and sector. One email per week.